The DOI matches its Crossref record; 128 of the 128 references it cites were found in a registry or an index.
Khat and synthetic cathinones: a review
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Arzneimittelforschung: Eine Zukunftsoption für Ärzte?
Bethke, T. D. (2012) · Der Pneumologe · doi:10.1007/s10405-012-0601-3 · Cited by 3,261
Boyer, E. W., & Shannon, M. (2005) · New England Journal of Medicine · doi:10.1056/nejmra041867 · Cited by 1,821
The Toxicology of Bath Salts: A Review of Synthetic Cathinones
Prosser, J. M., & Nelson, L. S. (2012) · Journal of Medical Toxicology · doi:10.1007/s13181-011-0193-z · Cited by 705
Pharmacological characterization of designer cathinones in vitro
Simmler, L., Buser, T., Donzelli, M., Schramm, Y., Dieu, L., Huwyler, J., Chaboz, S., Hoener, M., & Liechti, M. (2013) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02145.x · Cited by 672
Spiller, H. A., Ryan, M. L., Weston, R. G., & Jansen, J. (2011) · Clinical Toxicology · doi:10.3109/15563650.2011.590812 · Cited by 522
Baumann, M. H., Ayestas, M. A., Partilla, J. S., Sink, J. R., Shulgin, A. T., Daley, P. F., Brandt, S. D., Rothman, R. B., Ruoho, A. E., & Cozzi, N. V. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2011.304 · Cited by 439
Toxicity of amphetamines: an update
Carvalho, M., Carmo, H., Costa, V. M., Capela, J. P., Pontes, H., Remião, F., Carvalho, F., & Bastos, M. D. L. (2012) · Archives of Toxicology · doi:10.1007/s00204-012-0815-5 · Cited by 431
Self-citationBaumann, M. H., Partilla, J. S., Lehner, K. R., Thorndike, E. B., Hoffman, A. F., Holy, M., Rothman, R. B., Goldberg, S. R., Lupica, C. R., Sitte, H. H., et al. (2013) · Neuropsychopharmacology · doi:10.1038/npp.2012.204 · Cited by 408
Bronstein, A. C., Spyker, D. A., Cantilena, L. R., Green, J. L., Rumack, B. H., & Dart, R. C. (2011) · Clinical Toxicology · doi:10.3109/15563650.2011.635149 · Cited by 388
Khat: pharmacological and medical aspects and its social use in Yemen
Al‐Motarreb, A., Baker, K., & Broadley, K. J. (2002) · Phytotherapy Research · doi:10.1002/ptr.1106 · Cited by 351
Cathinone derivatives: A review of their chemistry, pharmacology and toxicology
Kelly, J. P. (2011) · Drug Testing and Analysis · doi:10.1002/dta.313 · Cited by 346
Mephedrone (4-methylmethcathinone; ‘meow meow’): chemical, pharmacological and clinical issues
Schifano, F., Albanese, A., Fergus, S., Stair, J. L., Deluca, P., Corazza, O., Davey, Z., Corkery, J., Siemann, H., Scherbaum, N., et al. (2011) · Psychopharmacology · doi:10.1007/s00213-010-2070-x · Cited by 315
Adverse effects of khat: a review
Cox, G., & Rampes, H. (2003) · Advances in Psychiatric Treatment · doi:10.1192/apt.9.6.456 · Cited by 302
Pharmacokinetics of cathinone, cathine and norephedrine after the chewing of khat leaves
Toennes, S. W., Harder, S., Schramm, M., Niess, C., & Kauert, G. F. (2003) · British Journal of Clinical Pharmacology · doi:10.1046/j.1365-2125.2003.01834.x · Cited by 295
Clinical toxicology of newer recreational drugs
Hill, S. L., & Thomas, S. H. L. (2011) · Clinical Toxicology · doi:10.3109/15563650.2011.615318 · Cited by 290
Meyer, M. R., Wilhelm, J., Peters, F. T., & Maurer, H. H. (2010) · Analytical and Bioanalytical Chemistry · doi:10.1007/s00216-010-3636-5 · Cited by 272
Medical aspects of the chewing of khat leaves.
Halbach, H. (1972) · PubMed · Cited by 268
Murray, B. L., Murphy, C. M., & Beuhler, M. C. (2012) · Journal of Medical Toxicology · doi:10.1007/s13181-011-0196-9 · Cited by 262
Amphetamine‐like effects in humans of the khat alkaloid cathinone.
Brenneisen, R., Fisch, H., Koelbing, U., Geisshusler, S., & Kalix, P. (1990) · British Journal of Clinical Pharmacology · doi:10.1111/j.1365-2125.1990.tb05447.x · Cited by 261
A web-based survey on mephedrone
Carhart-Harris, R. L., King, L. A., & Nutt, D. J. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.02.011 · Cited by 244
Dargan, P. I., Albert, S., & Wood, D. M. (2010) · QJM · doi:10.1093/qjmed/hcq134 · Cited by 242
4-Methylmethcathinone (Mephedrone): Neuropharmacological Effects of a Designer Stimulant of Abuse
Hadlock, G. C., Webb, K. M., McFadden, L. M., Chu, P. W., Ellis, J. D., Allen, S. C., Andrenyak, D. M., Vieira-Brock, P. L., German, C. L., Conrad, K. M., et al. (2011) · The Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.111.184119 · Cited by 242
Coppola, M., & Mondola, R. (2012) · Toxicology Letters · doi:10.1016/j.toxlet.2012.03.009 · Cited by 239
Pharmacodynamics and pharmacokinetics of khat: A controlled study
Widler, P., Mathys, K., Brenneisen, R., Kalix, P., & Fisch, H.-U. (1994) · Clinical Pharmacology and Therapeutics · doi:10.1038/clpt.1994.69 · Cited by 232
Borek, H. A., & Holstege, C. P. (2012) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2012.01.005 · Cited by 223
Case series of individuals with analytically confirmed acute mephedrone toxicity
Wood, D. M., Davies, S., Greene, S. L., Button, J., Holt, D. W., Ramsey, J., & Dargan, P. I. (2010) · Clinical Toxicology · doi:10.3109/15563650.2010.531021 · Cited by 215
Instability of the ecstasy market and a new kid on the block: mephedrone
Brunt, T. M., Poortman, A., Niesink, R. J., & van den Brink, W. (2011) · Journal of Psychopharmacology · doi:10.1177/0269881110378370 · Cited by 215
James, D., Adams, R. D., Spears, R., Cooper, G., Lupton, D. J., Thompson, J. P., Thomas, S. H. L., & Service, O. B. O. T. N. P. I. (2011) · Emergency Medicine Journal · doi:10.1136/emj.2010.096636 · Cited by 214
Marinetti, L. J., & Antonides, H. M. (2013) · Journal of Analytical Toxicology · doi:10.1093/jat/bks136 · Cited by 213
Purchasing 'legal highs' on the Internet--is there consistency in what you get?
Davies, S., Wood, D. M., Smith, G., Button, J., Ramsey, J., Archer, R., Holt, D. W., & Dargan, P. I. (2010) · QJM · doi:10.1093/qjmed/hcq056 · Cited by 212
Psychoactive “bath salts”: Not so soothing
Baumann, M. H., Partilla, J. S., & Lehner, K. R. (2013) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2012.11.020 · Cited by 208
Wood, D. M., Davies, S., Puchnarewicz, M., Button, J., Archer, R., Ovaska, H., Ramsey, J., Lee, T., Holt, D. W., & Dargan, P. I. (2010) · Journal of Medical Toxicology · doi:10.1007/s13181-010-0018-5 · Cited by 206
A review of the neuropharmacological properties of khat
Feyissa, A. M., & Kelly, J. P. (2008) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2007.12.033 · Cited by 199
López‐Arnau, R., Martínez‐Clemente, J., Pubill, D., Escubedo, E., & Camarasa, J. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.01998.x · Cited by 196
Al-Motarreb, A., Al-Habori, M., & Broadley, K. J. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.07.001 · Cited by 196
Inhibition of plasma membrane monoamine transporters by β-ketoamphetamines
Cozzi, N. V., Sievert, M. K., Shulgin, A. T., Jacob, P., & Ruoho, A. E. (1999) · European Journal of Pharmacology · doi:10.1016/s0014-2999(99)00538-5 · Cited by 194
The prevalence and socio‐demographic correlates of khat chewing in Butajira, Ethiopia
Alem, A., Kebede, D., & Kullgren, G. (1999) · Acta Psychiatrica Scandinavica · doi:10.1111/j.1600-0447.1999.tb10699.x · Cited by 191
A case of extreme agitation and death after the use of mephedrone in The Netherlands
Lusthof, K. J., Oosting, R., Maes, A., Verschraagen, M., Dijkhuizen, A., & Sprong, A. G. A. (2011) · Forensic Science International · doi:10.1016/j.forsciint.2010.12.014 · Cited by 190
Aarde, S. M., Huang, P. K., Creehan, K. M., Dickerson, T. J., & Taffe, M. A. (2013) · Neuropharmacology · doi:10.1016/j.neuropharm.2013.04.003 · Cited by 186
Balint, E. E., Falkay, G., & Balint, G. A. (2009) · Wiener klinische Wochenschrift · doi:10.1007/s00508-009-1259-7 · Cited by 183
Mephedrone (4-Methylmethcathinone)-Related Deaths
Maskell, P. D., De Paoli, G., Seneviratne, C., & Pounder, D. J. (2011) · Journal of Analytical Toxicology · doi:10.1093/anatox/35.3.188 · Cited by 179
The potential adverse effects of habitual use of Catha edulis(khat)
Al-Habori, M. (2005) · Expert Opinion on Drug Safety · doi:10.1517/14740338.4.6.1145 · Cited by 178
Watterson, L. R., Kufahl, P. R., Nemirovsky, N. E., Sewalia, K., Grabenauer, M., Thomas, B. F., Marusich, J. A., Wegner, S., & Olive, M. F. (2014) · Addiction Biology · doi:10.1111/j.1369-1600.2012.00474.x · Cited by 176
Three Fatal Intoxications Due to Methylone
Pearson, J. M., Hargraves, T. L., Hair, L. S., Massucci, C. J., Clinton Frazee, C., Garg, U., & Pietak, B. R. (2012) · Journal of Analytical Toxicology · doi:10.1093/jat/bks043 · Cited by 171
Drugs for youth via Internet and the example of mephedrone
Vardakou, I., Pistos, C., & Spiliopoulou, C. (2011) · Toxicology Letters · doi:10.1016/j.toxlet.2010.12.014 · Cited by 170
An analysis of the ‘legal high’ mephedrone
Gibbons, S., & Zloh, M. (2010) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2010.05.065 · Cited by 163
Measham, F. C., Wood, D. M., Dargan, P. I., & Moore, K. (2011) · Journal of Substance Use · doi:10.3109/14659891.2011.594704 · Cited by 154
Fantegrossi, W. E., Gannon, B. M., Zimmerman, S. M., & Rice, K. C. (2012) · Neuropsychopharmacology · doi:10.1038/npp.2012.233 · Cited by 152
Lethal Serotonin Syndrome After Methylone and Butylone Ingestion
Warrick, B. J., Wilson, J., Hedge, M. W., Freeman, S. B., Leonard, K., & Aaron, C. K. (2011) · Journal of Medical Toxicology · doi:10.1007/s13181-011-0199-6 · Cited by 152
McElrath, K., & O’Neill, C. (2011) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2010.11.001 · Cited by 144
Cathinone: An Investigation of Several N-Alkyl and Methylenedioxy-Substituted Analogs
Cason, T. A. D., Young, R., & Glennon, R. A. (1997) · Pharmacology Biochemistry and Behavior · doi:10.1016/s0091-3057(97)00323-7 · Cited by 125
Martínez-Clemente, J., López‐Arnau, R., Carbó, M., Pubill, D., Camarasa, J., & Escubedo, E. (2013) · Psychopharmacology · doi:10.1007/s00213-013-3108-7 · Cited by 124
Metabolism of the recently encountered designer drug, methylone, in humans and rats
Kamata, H., Shima, N., Zaitsu, K., Kamata, T., Miki, A., Nishikawa, M., Katagi, M., & Tsuchihashi, H. (2006) · Xenobiotica · doi:10.1080/00498250600780191 · Cited by 120
Lisek, R., Xu, W., Yuvasheva, E., Chiu, Y.-T., Reitz, A. B., Liu‐Chen, L., & Rawls, S. M. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.04.021 · Cited by 120
Bupropion hydrochloride ((±) α-t-butylamino-3-chloropropiophenone HCl): a novel antidepressant agent
Soroko, F. E., Mehta, N. B., Maxwell, R. A., Ferris, R. M., & Schroeder, D. H. (1977) · Journal of Pharmacy and Pharmacology · doi:10.1111/j.2042-7158.1977.tb11460.x · Cited by 119
Khat chewing in Yemen: turning over a new leaf
Al-Mugahed, L. (2008) · Bulletin of the World Health Organization · doi:10.2471/blt.08.011008 · Cited by 119
Ali, W. M., Zubaid, M., Al‐Motarreb, A., Singh, R., Al-Shereiqi, S. Z., Shehab, A., Rashed, W. A., Al‐Sagheer, N. Q., Saleh, A. H., & Suwaidi, J. M. S. A. (2010) · Mayo Clinic Proceedings · doi:10.4065/mcp.2010.0398 · Cited by 117
Szendrei, K. (1980) · PubMed · Cited by 115
Long-term cognitive and neurochemical effects of “bath salt” designer drugs methylone and mephedrone
den Hollander, B., Rozov, S. V., Linden, A.-M., Uusi‐Oukari, M., Ojanperä, I. A., & Korpi, E. R. (2012) · Pharmacology Biochemistry and Behavior · doi:10.1016/j.pbb.2012.10.006 · Cited by 113
Methylone and mCPP, two new drugs of abuse?
Bossong, M. G., Dijk, J. V., & Niesink, R. J. M. (2005) · Addiction Biology · doi:10.1080/13556210500350794 · Cited by 112
Sudden Cardiac Death Associated With Methylone Use
Carbone, P. N., Carbone, D. L., Carstairs, S. D., & Luzi, S. A. (2013) · American Journal of Forensic Medicine & Pathology · doi:10.1097/paf.0b013e31827ab5da · Cited by 110
Synthetic legal intoxicating drugs: The emerging ‘incense’ and ‘bath salt’ phenomenon
Jerry, J. M., Collins, G. B., & Streem, D. W. (2012) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.79a.11147 · Cited by 110
Angoa‐Pérez, M., Kane, M. J., Francescutti, D. M., Sykes, K. E., Shah, M. M., Mohammed, A. M., Thomas, D. M., & Kuhn, D. M. (2011) · Journal of Neurochemistry · doi:10.1111/j.1471-4159.2011.07632.x · Cited by 109
Cameron, K. N., Kolanoś, R., Solis, E., Glennon, R. A., & DeFelice, L. J. (2012) · British Journal of Pharmacology · doi:10.1111/bph.12061 · Cited by 108
Tesfaye, F., Byass, P., Wall, S., Berhane, Y., & Bonita, R. (2008) · PubMed Central · Cited by 108
Manganese-Induced Parkinsonism Associated With Methcathinone (Ephedrone) Abuse
de Bie, R. M. A., Gladstone, R. M., Strafella, A. P., Ko, J. H., & Lang, A. E. (2007) · Archives of Neurology · doi:10.1001/archneur.64.6.886 · Cited by 108
Khat Use Is Associated with Impaired Working Memory and Cognitive Flexibility
Colzato, L. S., Ruiz, M. J., van den Wildenberg, W. P. M., & Hommel, B. (2011) · PLoS ONE · doi:10.1371/journal.pone.0020602 · Cited by 108
Baclofen overdose mimicking brain death
Sullivan, R. W., Hodgman, M. J., Kao, L. W., & Tormoehlen, L. M. (2012) · Clinical Toxicology · doi:10.3109/15563650.2011.654209 · Cited by 105
Shortall, S. E., Macerola, A. E., Swaby, R., Jayson, R., Korsah, C., Pillidge, K., Wigmore, P. M., Ebling, F. J. P., Green, A. R., Fone, K. C. F., et al. (2012) · European Neuropsychopharmacology · doi:10.1016/j.euroneuro.2012.09.005 · Cited by 103
Miller, M. L., Creehan, K. M., Angrish, D., Barlow, D. J., Houseknecht, K. L., Dickerson, T. J., & Taffe, M. A. (2012) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2012.07.003 · Cited by 100
Chronic khat use and psychotic disorders: A review of the literature and future prospects
Odenwald, M. G. (2007) · SUCHT - Zeitschrift für Wissenschaft und Praxis / Journal of Addiction Research and Practice · doi:10.1024/2007.01.03 · Cited by 98
Bulletin de la Société chimique de France
de chimie, S. F. (1997) · Medical Entomology and Zoology · Cited by 95
Severe, Acute Liver Injury and Khat Leaves
Chapman, M. H., Kajihara, M., Borges, G., et al. (2010) · New England Journal of Medicine · doi:10.1056/nejmc0908038 · Cited by 95
Sauer, C., Peters, F. T., Haas, C., Meyer, M. R., Fritschi, G., & Maurer, H. H. (2009) · Journal of Mass Spectrometry · doi:10.1002/jms.1571 · Cited by 95
Thornton, S. L., Gerona, R. R. L., & Tomaszewski, C. (2012) · Journal of Medical Toxicology · doi:10.1007/s13181-012-0232-4 · Cited by 93
Wright, M. J., Angrish, D., Aarde, S. M., Barlow, D. J., Buczynski, M. W., Creehan, K. M., Vandewater, S. A., Parsons, L. H., Houseknecht, K. L., Dickerson, T. J., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0044652 · Cited by 93
Motbey, C. P., Hunt, G. E., Bowen, M. T., Artiss, S., & McGregor, I. S. (2011) · Addiction Biology · doi:10.1111/j.1369-1600.2011.00384.x · Cited by 93
GHB and synthetic cathinones: clinical effects and potential consequences
Karila, L., & Reynaud, M. (2010) · Drug Testing and Analysis · doi:10.1002/dta.210 · Cited by 92
Motbey, C. P., Clemens, K. J., Apetz, N., WINSTOCK, A. R., Ramsey, J., Li, K. M., Wyatt, N. A., Callaghan, P. D., Bowen, M. T., Cornish, J. L., et al. (2013) · Journal of Psychopharmacology · doi:10.1177/0269881113490325 · Cited by 85
Springer, D., Fritschi, G., & Maurer, H. H. (2003) · Journal of Chromatography B · doi:10.1016/j.jchromb.2003.07.008 · Cited by 83
Excited delirium following use of synthetic cathinones (bath salts)
Penders, T. M., Gestring, R. E., & Vilensky, D. A. (2012) · General Hospital Psychiatry · doi:10.1016/j.genhosppsych.2012.06.005 · Cited by 82
Recurrent Acute Kidney Injury Following Bath Salts Intoxication
Adebamiro, A., & Perazella, M. A. (2011) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2011.10.012 · Cited by 81
Excretion and Detection of Cathinone, Cathine, and Phenylpropanolamine in Urine after Kath Chewing
Toennes, S. W., & Kauert, G. F. (2002) · Clinical Chemistry · doi:10.1093/clinchem/48.10.1715 · Cited by 79
Headshop heartache: acute mephedrone ‘meow’ myocarditis
Nicholson, P. J., Quinn, M. J., & Dodd, J. D. (2010) · Heart · doi:10.1136/hrt.2010.209338 · Cited by 79
Manganic encephalopathy due to “ephedrone” abuse
Sanotsky, Y., Lesyk, R., Fedoryshyn, L., Komnatska, I., Matviyenko, Y., & Fahn, S. (2007) · Movement Disorders · doi:10.1002/mds.21378 · Cited by 78
Kasick, D. P., McKnight, C. A., & Klisovic, E. S. (2012) · The American Journal of Drug and Alcohol Abuse · doi:10.3109/00952990.2011.643999 · Cited by 78
Methcathinone: A russian designer amphetamine infiltrates the rural midwest
Emerson, T. S., & Cisek, J. (1993) · Annals of Emergency Medicine · doi:10.1016/s0196-0644(05)80419-6 · Cited by 76
Bupropion: clinical assay for amphetamine-like abuse potential.
Griffith, J. D., Carranza, J., Griffith, C., & Miller, L. L. (1983) · PubMed · Cited by 75
Angoa‐Pérez, M., Kane, M. J., Briggs, D. I., Francescutti, D. M., Sykes, C. E., Shah, M. M., Thomas, D. M., & Kuhn, D. M. (2012) · Journal of Neurochemistry · doi:10.1111/jnc.12114 · Cited by 74
Seizures and Hyponatremia Related to Ethcathinone and Methylone Poisoning
Boulanger-Gobeil, C., St-Onge, M., Laliberté, M., & Auger, P. L. (2011) · Journal of Medical Toxicology · doi:10.1007/s13181-011-0159-1 · Cited by 71
Springer, D., Fritschi, G., & Maurer, H. H. (2003) · Journal of Chromatography B · doi:10.1016/s1570-0232(03)00334-9 · Cited by 70
Sparago, M., Wlos, J., Yuan, J., Hatzidimitriou, G., Tolliver, J., Cason, T. A. D., Katz, J. L., & Ricaurte, G. A. (1996) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1016/s0022-3565(25)21220-4 · Cited by 69
Letter: Metaclopramide and prolactin.
McNeilly, A. S., Thorner, M. O., Volans, G. N., & BESSER, G. M. (1974) · BMJ · doi:10.1136/bmj.2.5921.729 · Cited by 68
Emerging psychoactive substance use among regular ecstasy users in Australia
Bruno, R., Matthews, A. J., Dunn, M., Alati, R., McIlwraith, F., Hickey, S. D., Burns, L., & Sindicich, N. (2011) · Drug and Alcohol Dependence · doi:10.1016/j.drugalcdep.2011.11.020 · Cited by 65
Serotonin Syndrome Associated With MDPV Use: A Case Report
Mugele, J., Nañagas, K., & Tormoehlen, L. M. (2012) · Annals of Emergency Medicine · doi:10.1016/j.annemergmed.2011.11.033 · Cited by 65
Mephedrone in Adolescent Rats: Residual Memory Impairment and Acute but Not Lasting 5-HT Depletion
Motbey, C. P., Karanges, E. A., Li, K. M., Wilkinson, S. M., WINSTOCK, A. R., Ramsay, J., Hicks, C., Kendig, M. D., Wyatt, N. A., Callaghan, P. D., et al. (2012) · PLoS ONE · doi:10.1371/journal.pone.0045473 · Cited by 64
Khat: an amphetamine-like plant material.
Kalix, P., & Khan, I. U. (1984) · PubMed · Cited by 62
López‐Arnau, R., Martínez-Clemente, J., Carbó, M., Pubill, D., Escubedo, E., & Camarasa, J. (2013) · Progress in Neuro-Psychopharmacology and Biological Psychiatry · doi:10.1016/j.pnpbp.2013.04.007 · Cited by 61
Neurotoxicity following chronic intravenous use of “Russian Cocktail”
Varlıbaş, F., DELİPOYRAZ, İ., Yüksel, G. A., Filiz, G., Tireli, H., & Geçim, N. O. (2009) · Clinical Toxicology · doi:10.1080/15563650802010388 · Cited by 60
Synthetic Cannabinoids and Cathinones: Prevalence and Markets.
Bretteville‐Jensen, A. L., Tuv, S. S., Bilgrei, O. R., Fjeld, B., & Bachs, L. C. (2013) · PubMed · Cited by 60
Springer, D., Fritschi, G., & Maurer, H. H. (2003) · Journal of Chromatography B · doi:10.1016/s1570-0232(03)00350-7 · Cited by 60
Clinical Toxicology and Management of Intoxications With Synthetic Cathinones (“Bath Salts”)
Mas-Morey, P., Visser, M., Mitrov‐Winkelmolen, L., & Touw, D. J. (2012) · Journal of Pharmacy Practice · doi:10.1177/0897190012465949 · Cited by 57
Shortall, S. E., Green, A. R., Swift, K., Fone, K. C. F., & King, M. V. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02236.x · Cited by 53
Mathys, K., & Brenneisen, R. (1992) · Journal of Chromatography A · doi:10.1016/0021-9673(92)80270-5 · Cited by 53
‘Bundle of fun’ or ‘bunch of problems’? Case series of khat-related deaths in the UK
Corkery, J., Schifano, F., Oyefeso, A. O., Ghodse, A. H., Tonia, T., Naidoo, V., & Button, J. (2010) · Drugs Education Prevention and Policy · doi:10.3109/09687637.2010.504200 · Cited by 53
The ambiguity of khat in Somaliland
Hansen, P. (2010) · Journal of Ethnopharmacology · doi:10.1016/j.jep.2010.02.028 · Cited by 52
Derungs, A., Schietzel, S., Meyer, M. R., Maurer, H. H., Krähenbühl, S., & Liechti, M. E. (2011) · Clinical Toxicology · doi:10.3109/15563650.2011.592838 · Cited by 52
Regulating khat—Dilemmas and opportunities for the international drug control system
Klein, A., Beckerleg, S., & Hailu, D. (2009) · International Journal of Drug Policy · doi:10.1016/j.drugpo.2009.05.002 · Cited by 48
Diethylpropion in the Treatment of "Refractory" Obesity
Seaton, D., Duncan, L. J. P., Rose, K., & Scott, A. M. (1961) · BMJ · doi:10.1136/bmj.1.5231.1009 · Cited by 46
Evaluation of pyrovalerone in chronically fatigued volunteers.
Gárdos, G., & Jo, C. (1971) · PubMed · Cited by 46
Repeated Catha edulis oral administration enhances the baseline aggressive behavior in isolated rats
Banjaw, M. Y., Miczek, K. A., & Schmidt, W. (2005) · Journal of Neural Transmission · doi:10.1007/s00702-005-0356-7 · Cited by 44
Arunotayanun, W., & Gibbons, S. (2012) · Natural Product Reports · doi:10.1039/c2np20068f · Cited by 43
Parkinsonism due to ephedrone neurotoxicity: a case report
Colosimo, C., & Guidi, M. (2009) · European Journal of Neurology · doi:10.1111/j.1468-1331.2009.02606.x · Cited by 42
Manganese toxicity with ephedrone abuse manifesting as parkinsonism: a case report
Iqbal, M., Monaghan, T., & Redmond, J. M. T. (2012) · Journal of Medical Case Reports · doi:10.1186/1752-1947-6-52 · Cited by 40
Wright, M. J., Vandewater, S., Angrish, D., Dickerson, T., & Taffe, M. (2012) · British Journal of Pharmacology · doi:10.1111/j.1476-5381.2012.02091.x · Cited by 39
The serotonin syndrome as a result of mephedrone toxicity
Garrett, G., & Sweeney, M. (2010) · BMJ Case Reports · doi:10.1136/bcr.04.2010.2925 · Cited by 39
Acute liver failure following recreational use of psychotropic “head shop” compounds
Fröhlich, S., Lambe, E., & O’Dea, J. (2010) · Irish Journal of Medical Science (1971 -) · doi:10.1007/s11845-010-0636-6 · Cited by 38
Case of Diethylpropion Addiction
Clein, L., & Benady, D. R. (1962) · BMJ · doi:10.1136/bmj.2.5302.456 · Cited by 36
Plant food for thought: A qualitative study of mephedrone use in Ireland
Hout, M. C. V., & Brennan, R. (2011) · Drugs Education Prevention and Policy · doi:10.3109/09687637.2010.537713 · Cited by 36
Herbal Marijuana Alternatives and Bath Salts—“Barely Legal” Toxic Highs
Lindsay, L., & White, M. L. (2012) · Clinical Pediatric Emergency Medicine · doi:10.1016/j.cpem.2012.09.001 · Cited by 30
Roelandt, P. R., George, C., d'Heygere, F., Aerts, R., Monbaliu, D. R. L., Laleman, W., Cassiman, D. M., Verslype, C., Steenbergen, W. V., Pirenne, J., et al. (2011) · Transplantation Proceedings · doi:10.1016/j.transproceed.2011.09.032 · Cited by 28
Virginia Commonwealth University, Richmond, VAPreprint
Klein, R. A., Burke, B., Ebersole, C. R., et al. (2017) · Cited by 17
RECENT ADVANCES IN KHAT RESEARCH
Kalix, P. (1984) · Alcohol and Alcoholism · doi:10.1093/oxfordjournals.alcalc.a044455 · Cited by 16
'Cat': Methcathinone—A New Drug of Abuse
Goldstone, M. S. (1993) · JAMA · doi:10.1001/jama.1993.03500190050033 · Cited by 14
Shima, N., Katagi, M., & Tsuchihashi, H. (2009) · Eisei kagaku · doi:10.1248/jhs.55.495 · Cited by 12
The involvement of dopamine in the central actions of bupropion, a new antidepressant [proceedings].
Canning, H., Goff, D., Leach, M. J., Miller, A. A., Tateson, J. E., & Wheatley, P. L. (1979) · PubMed Central · Cited by 9
Diethylpropion in the treatment of obesity.
Cunningham, G. (1963) · PubMed · Cited by 9
Cited by
New psychoactive substances: a review and updates
Shafi, A., Berry, A. J., Sumnall, H., Wood, D. M., & Tracy, D. K. (2020) · Therapeutic Advances in Psychopharmacology · doi:10.1177/2045125320967197 · Cited by 347
The hallucinogenic world of tryptamines: an updated review
Araújo, A. M., Carvalho, F., Bastos, M. D. L., Guedes de Pinho, P., & Carvalho, M. (2015) · Archives of Toxicology · doi:10.1007/s00204-015-1513-x · Cited by 292
Self-citationDesigner drugs: mechanism of action and adverse effects
Luethi, D., & Liechti, M. E. (2020) · Archives of Toxicology · doi:10.1007/s00204-020-02693-7 · Cited by 262
Shifting drug markets in North America - a global crisis in the making?
Meyer, M., Westenberg, J. N., Jang, K. L., Choi, F., Schreiter, S., Mathew, N., King, C., Lang, U. E., Vogel, M., & Krausz, R. M. (2023) · International Journal of Mental Health Systems · doi:10.1186/s13033-023-00601-x · Cited by 41
“In North America and Europe alike, they have commonly been sold legally (e.g., as bath salts) and mis-sold illegally as MDMA [35–37].”
Background
Metadata
- Authors
- Valente, M. J., Guedes de Pinho, P., de Lourdes Bastos, M., Carvalho, F., & Carvalho, M.
- Venue
- Archives of Toxicology
- Published
- 2013-12-08
- Volume
- 88
- Issue
- 1
- Pages
- 15-45
- ISSN
- 0340-5761 (ISSN-L)
- 1432-0738
- OpenAlex
- W2032821512
- Cited by
- 337
- References
- 128
- FWCI
- 21.61
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.